サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765280

治療的血漿交換の世界市場

Therapeutic Plasma Exchange

出版日
ページ情報
英文 197 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
治療的血漿交換の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

治療的血漿交換の世界市場は2030年までに21億米ドルに達する

2024年に15億米ドルと推定される治療的血漿交換の世界市場は、2024～2030年の分析期間においてCAGR 6.2%で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである神経疾患は、CAGR 6.9%を記録し、分析期間終了時には7億8,960万米ドルに達すると予測されます。腎障害分野の成長率は、分析期間中CAGR 5.3％と推定されます。

米国市場は4億1,010万米ドルと推定、中国はCAGR 5.7%で成長予測

米国の治療的血漿交換市場は、2024年に4億1,010万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR5.7％を引きずる形で、2030年までに3億3,170万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.5%と5.1%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の治療的血漿交換市場- 主要動向と促進要因のまとめ

現代のヘルスケアにおいて治療的血漿交換が重要な理由とは？

治療的血漿交換（TPE）は、さまざまな自己免疫疾患、血液疾患、神経疾患の治療における救命処置として登場しました。この方法は、患者の血液から血漿を除去し、新鮮な血漿または血漿代替物で置換するもので、有害な抗体や毒素を除去するのに役立ちます。ギラン・バレー症候群、重症筋無力症、多発性硬化症などの治療におけるTPEの使用が増加していることから、ヘルスケアにおけるTPEの重要な役割が強調されています。血漿交換の利点に対する認識が高まるにつれ、より多くの患者や医療提供者がこの療法を利用するようになり、治療的血漿交換市場は近年大幅に拡大しています。

さまざまな用途と技術が市場をどのように牽引しているか？

技術別では、遠心分離法と膜ろ過法が最も一般的に採用されている方法で、それぞれに明確な利点があります。遠心ベースのシステムは神経疾患の治療に広く使用されているのに対し、膜ろ過は腎疾患や特定の血液疾患に好まれています。適応疾患は自己免疫疾患から血液疾患、その他の重篤な疾患まで多岐にわたる。エンドユーザー別では、病院、専門クリニック、献血センターが市場を独占しており、慢性疾患管理のためにTPE処置を採用する外来患者施設が増加しています。TPEを取り入れた治療の選択肢が増えていることが、市場全体の裾野を広げています。

どのような革新が治療的血漿交換の将来を形成しているのか？

技術の進歩により、より効率的で安全、かつ使いやすい血漿交換システムが開発され、ヘルスケアプロバイダーにとって血漿交換がより身近なものとなっています。強化された安全機能を備えた自動アフェレシス装置は、ますます標準治療となりつつあり、処置時間の短縮と患者の転帰の改善につながっています。さらに、TPEシステムにリアルタイムのモニタリングとデータ分析機能が統合されたことで、医療提供者は患者固有の状態に基づいて治療をカスタマイズできるようになりました。さらに、免疫抑制療法など他の治療法と組み合わせる傾向が強まっており、慢性疾患管理の様相を変えつつあります。

治療的血漿交換市場の成長促進要因は？

治療的血漿交換市場の成長は、自己免疫疾患の有病率の上昇、神経疾患の治療におけるTPEの使用の増加、新規血漿交換デバイスの承認件数の増加など、いくつかの要因によってもたらされます。アフェレシス装置の技術革新は、ヘルスケア・インフラへの投資の増加と相まって、TPEの採用を拡大しています。さらに、重篤な医療環境におけるTPEによる早期介入の利点に関する医療専門家の意識の高まりが、血漿交換の需要を押し上げています。特に希少で複雑な疾患の治療において、TPEの対象となる患者層が拡大していることが、市場の成長をさらに後押ししています。最後に、携帯可能で費用対効果の高い血漿交換システムの開発により、この救命療法がより身近なものとなり、今後数年間の市場拡大が見込まれます。

セグメント

適応疾患（神経疾患、腎疾患、血液疾患、代謝疾患、その他の疾患）、最終用途（病院、専門クリニック、外来手術センター）

調査対象企業の例

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15189

Global Therapeutic Plasma Exchange Market to Reach US$2.1 Billion by 2030

The global market for Therapeutic Plasma Exchange estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.1 Million While China is Forecast to Grow at 5.7% CAGR

The Therapeutic Plasma Exchange market in the U.S. is estimated at US$410.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$331.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Therapeutic Plasma Exchange Market - Key Trends and Drivers Summarized

What Makes Therapeutic Plasma Exchange Critical in Modern Healthcare?

Therapeutic plasma exchange (TPE) has emerged as a life-saving procedure in treating various autoimmune diseases, hematological conditions, and neurological disorders. This procedure involves the removal of plasma from a patient's blood and its replacement with fresh plasma or a plasma substitute, which helps eliminate harmful antibodies and toxins. The increasing use of TPE in treating conditions such as Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis has underscored its critical role in healthcare. As awareness of the benefits of plasma exchange grows, more patients and healthcare providers are turning to this therapy, which has significantly expanded the therapeutic plasma exchange market in recent years.

How Are Different Applications and Technologies Driving the Market?

By technology, centrifugal-based and membrane filtration techniques are the most commonly employed methods, each offering distinct advantages. Centrifugal-based systems are widely used in treating neurological conditions, whereas membrane filtration is preferred for renal disorders and certain hematological diseases. Disease indication segments range from autoimmune disorders to blood dyscrasias and other critical illnesses. In terms of end-users, hospitals, specialty clinics, and blood donation centers dominate the market, with a growing number of outpatient facilities adopting TPE procedures for chronic disease management. The rising number of treatment options that incorporate TPE is expanding the market’s overall reach.

What Innovations Are Shaping the Future of Therapeutic Plasma Exchange?

Technological advancements have led to more efficient, safe, and user-friendly plasma exchange systems, making the procedure more accessible to healthcare providers. Automated apheresis devices, equipped with enhanced safety features, are increasingly becoming the standard of care, reducing procedure time and improving patient outcomes. Moreover, the integration of real-time monitoring and data analytics in TPE systems allows healthcare providers to customize treatments based on patient-specific conditions. Additionally, the growing trend of combining therapeutic plasma exchange with other treatment modalities, such as immunosuppressive therapies, is transforming the landscape of chronic disease management.

What Are the Key Drivers of Growth in the Therapeutic Plasma Exchange Market?

The growth in the therapeutic plasma exchange market is driven by several factors, including the rising prevalence of autoimmune diseases, the increased use of TPE in treating neurological conditions, and the growing number of regulatory approvals for novel plasma exchange devices. Technological innovations in apheresis devices, coupled with rising investments in healthcare infrastructure, are expanding the adoption of TPE. Additionally, increasing awareness among healthcare professionals about the benefits of early intervention with TPE in critical care settings is boosting the demand for plasma exchange. The expanding base of patients eligible for TPE, particularly in the treatment of rare and complex disorders, further propels market growth. Lastly, the development of portable and more cost-effective plasma exchange systems is expected to make this life-saving therapy more accessible, driving market expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Therapeutic Plasma Exchange market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Other Disease Indications); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Therapeutic Plasma Exchange - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Autoimmune Diseases Propels Growth of Therapeutic Plasma Exchange Market
    • Rising Demand for Non-invasive Therapeutic Solutions Strengthens Adoption of Plasma Exchange
    • Increasing Application of Therapeutic Plasma Exchange in Neurological Disorders Expands Market Opportunity
    • Advances in Medical Device Technologies Drive the Efficiency of Plasma Exchange Systems
    • Growing Use of Therapeutic Plasma Exchange in Pediatric Applications Spurs Market Growth
    • Rising Focus on Plasma-based Treatments for Critical Illnesses Drives Adoption of Therapeutic Plasma Exchange
    • Technological Innovations in Apheresis Systems Generate Demand for Advanced Plasma Exchange Solutions
    • Increased Awareness of Plasma Donation Programs Expands Adoption of Plasma Exchange Treatments
    • Growing Number of Plasma Collection Centers Propels the Therapeutic Plasma Exchange Market
    • Integration of AI and Data Analytics in Plasma Exchange Systems Strengthens Operational Efficiency
    • Surge in Clinical Trials Exploring Plasma Exchange for Emerging Therapies Boosts Market Demand
    • Increasing Use of Plasma Exchange in Immunology and Hematology Drives Market Expansion
    • Rising Prevalence of Infectious Diseases Spurs Demand for Plasma-based Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Therapeutic Plasma Exchange Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Renal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hematology Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION